Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • الموضوع:
    • نبذة مختصرة :
      The lack of treatment options for high-grade brain tumors has led to searches for alternative therapeutic modalities. Electrical field therapy is one such area. The Optune™ system is an FDA-approved novel device that delivers continuous alternating electric fields (tumor treating fields-TTFields) to the patient for the treatment of primary and recurrent Glioblastoma multiforme (GBM). Various mechanisms have been proposed to explain the effects of TTFields and other electrical therapies. Here, we present the first study of genome-wide expression of electrotherapy (delivered via TTFields or Deep Brain Stimulation (DBS)) on brain tumor cell lines. The effects of electric fields were assessed through gene expression arrays and combinational effects with chemotherapies. We observed that both DBS and TTFields significantly affected brain tumor cell line viability, with DBS promoting G0-phase accumulation and TTFields promoting G2-phase accumulation. Both treatments may be used to augment the efficacy of chemotherapy in vitro. Genome-wide expression assessment demonstrated significant overlap between the different electrical treatments, suggesting novel interactions with mitochondrial functioning and promoting endoplasmic reticulum stress. We demonstrate the in vitro efficacy of electric fields against adult and pediatric high-grade brain tumors and elucidate potential mechanisms of action for future study.
    • References:
      Neuro Oncol. 2016 Aug;18(8):1129-36. (PMID: 27177573)
      BMC Med Phys. 2009 Jan 08;9:1. (PMID: 19133110)
      Sci Rep. 2018 May 8;8(1):7301. (PMID: 29740075)
      Nature. 2019 Sep;573(7775):532-538. (PMID: 31534219)
      Int J Cancer. 2016 Dec 15;139(12):2850-2858. (PMID: 27561100)
      Neuroscientist. 2016 Jun;22(3):313-22. (PMID: 25888630)
      Eur J Cancer. 2012 Sep;48(14):2192-202. (PMID: 22608262)
      Anticancer Res. 2016 Jan;36(1):71-80. (PMID: 26722029)
      Handb Clin Neurol. 2013;116:39-54. (PMID: 24112883)
      Cell Death Discov. 2018 Oct 3;4:46. (PMID: 30302280)
      Mol Cell Biol. 2000 Feb;20(3):805-15. (PMID: 10629037)
      Cell Death Dis. 2017 Apr 20;8(4):e2753. (PMID: 28425987)
      Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10152-7. (PMID: 17551011)
      Exp Mol Med. 2013 Oct 04;45:e45. (PMID: 24091747)
      PLoS One. 2015 May 26;10(5):e0125269. (PMID: 26010837)
      J Clin Neurosci. 2017 Feb;36:120-124. (PMID: 27865821)
      N Engl J Med. 2005 Mar 10;352(10):997-1003. (PMID: 15758010)
      Cancer Res. 2004 May 1;64(9):3288-95. (PMID: 15126372)
      Front Physiol. 2013 Jul 17;4:185. (PMID: 23882223)
      PLoS One. 2018 Aug 22;13(8):e0201957. (PMID: 30133493)
      Cell Death Discov. 2018 Dec 5;4:113. (PMID: 30534421)
      Sci Rep. 2015 Dec 11;5:18046. (PMID: 26658786)
      Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516. (PMID: 16932614)
      Nature. 2006 Oct 19;443(7113):787-95. (PMID: 17051205)
      Cell Death Dis. 2018 Oct 19;9(11):1074. (PMID: 30341282)
      Neuro Oncol. 2016 Mar;18(3):303-5. (PMID: 26917587)
      JAMA. 2017 Dec 19;318(23):2306-2316. (PMID: 29260225)
      Cell. 2015 May 7;161(4):803-16. (PMID: 25913192)
      J Vis Exp. 2017 May 4;(123):. (PMID: 28518093)
      Cell Death Discov. 2018 Jul 16;4:12. (PMID: 30210815)
      N Engl J Med. 2005 Mar 10;352(10):987-96. (PMID: 15758009)
      IEEE Rev Biomed Eng. 2018;11:195-207. (PMID: 29993870)
      Glia. 2005 Jul;51(1):65-72. (PMID: 15779084)
    • Grant Information:
      CCLGA201916 Children's Cancer and Leukaemia Group
    • Contributed Indexing:
      Keywords: Deep Brain Stimulation; ependymoma; glioma; tumor treating fields
    • الموضوع:
      Date Created: 20220226 Date Completed: 20220316 Latest Revision: 20220316
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC8880247
    • الرقم المعرف:
      10.3390/ijms23041982
    • الرقم المعرف:
      35216098